Oppenheimer Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.16M | Buy |
+7,365
| New | +$2.42M | 0.02% | 530 |
|
|
2025
Q4 | – | Sell |
-6,247
| Closed | -$2.02M | – | 1141 |
|
|
2025
Q3 | $2.02M | Sell |
6,247
-10,300
| -62% | -$3.2M | 0.02% | 559 |
|
|
2025
Q2 | $6.44M | Buy |
16,547
+1,311
| +9% | +$527K | 0.07% | 294 |
|
|
2025
Q1 | $6.63M | Buy |
15,236
+7,380
| +94% | +$2.96M | 0.08% | 264 |
|
|
2024
Q4 | $2.9M | Buy |
7,856
+158
| +2% | +$66.1K | 0.04% | 449 |
|
|
2024
Q3 | $4M | Buy |
7,698
+118
| +2% | +$63K | 0.05% | 378 |
|
|
2024
Q2 | $4.11M | Buy |
7,580
+2,386
| +46% | +$1.26M | 0.05% | 352 |
|
|
2024
Q1 | $2.69M | Sell |
5,194
-3,995
| -43% | -$1.99M | 0.04% | 410 |
|
|
2023
Q4 | $4.33M | Buy |
9,189
+279
| +3% | +$129K | 0.06% | 326 |
|
|
2023
Q3 | $3.88M | Buy |
8,910
+862
| +11% | +$391K | 0.06% | 335 |
|
|
2023
Q2 | $3.58M | Buy |
8,048
+4,327
| +116% | +$2M | 0.05% | 366 |
|
|
2023
Q1 | $1.71M | Sell |
3,721
-932
| -20% | -$444K | 0.03% | 539 |
|
|
2022
Q4 | $2.39M | Sell |
4,653
-2,698
| -37% | -$1.37M | 0.04% | 429 |
|
|
2022
Q3 | $3.34M | Sell |
7,351
-23
| -0.3% | -$11K | 0.06% | 324 |
|
|
2022
Q2 | $3.56M | Buy |
7,374
+1,646
| +29% | +$814K | 0.06% | 330 |
|
|
2022
Q1 | $2.81M | Buy |
5,728
+960
| +20% | +$439K | 0.04% | 428 |
|
|
2021
Q4 | $2.21M | Sell |
4,768
-2,090
| -30% | -$879K | 0.03% | 525 |
|
|
2021
Q3 | $2.56M | Buy |
6,858
+1,697
| +33% | +$645K | 0.04% | 456 |
|
|
2021
Q2 | $1.97M | Buy |
5,161
+1,384
| +37% | +$529K | 0.03% | 546 |
|
|
2021
Q1 | $1.35M | Buy |
3,777
+316
| +9% | +$102K | 0.02% | 636 |
|
|
2020
Q4 | $1.11M | Buy |
+3,461
| New | +$1.06M | 0.02% | 660 |
|
|
2020
Q2 | – | Sell |
-441
| Closed | -$99K | – | 1170 |
|
|
2020
Q1 | $99K | Sell |
441
-313
| -42% | -$85.3K | ﹤0.01% | 1108 |
|
|
2019
Q4 | $229K | Sell |
754
-32
| -4% | -$8.81K | ﹤0.01% | 1029 |
|
|
2019
Q3 | $189K | Sell |
786
-820
| -51% | -$225K | ﹤0.01% | 1048 |
|
|
2019
Q2 | $455K | Sell |
1,606
-66
| -4% | -$18K | 0.01% | 841 |
|
|
2019
Q1 | $480K | Sell |
1,672
-2,542
| -60% | -$735K | 0.01% | 817 |
|
|
2018
Q4 | $1.11M | Buy |
4,214
+1,005
| +31% | +$276K | 0.03% | 530 |
|
|
2018
Q3 | $878K | Buy |
3,209
+199
| +7% | +$51.7K | 0.02% | 651 |
|
|
2018
Q2 | $716K | Buy |
3,010
+79
| +3% | +$18.3K | 0.02% | 687 |
|
|
2018
Q1 | $643K | Sell |
2,931
-430
| -13% | -$101K | 0.02% | 715 |
|
|
2017
Q4 | $638K | Hold |
3,361
| – | – | 0.02% | 723 |
|
|
2017
Q3 | $638K | Buy |
3,361
+331
| +11% | +$63K | 0.02% | 727 |
|
|
2017
Q2 | $570K | Buy |
3,030
+754
| +33% | +$135K | 0.02% | 743 |
|
|
2017
Q1 | $375K | Buy |
+2,276
| New | +$362K | 0.01% | 861 |
|
Other funds holding ELV
VCM
VPM
Oppenheimer Asset Management's ELV Position: Q1 2026 in Review
Oppenheimer Asset Management opened a new position in Elevance Health (ELV) in Q1 2026: 7,365 shares worth $2.16M. The stake represents 0.02% of the portfolio and ranks #530 among its holdings. This is a return to the name: Oppenheimer Asset Management previously reported a position in ELV as recently as Q3 2025.
Oppenheimer Asset Management first reported a position in ELV in Q1 2017 and has held it in 34 quarters since. The position peaked at $6.63M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Oppenheimer Asset Management held 7,365 shares of Elevance Health worth $2.16M as of Q1 2026.
- Elevance Health was a new Oppenheimer Asset Management position in Q1 2026.
- Elevance Health made up 0.02% of Oppenheimer Asset Management's portfolio in Q1 2026, its #530 holding.
- Oppenheimer Asset Management first reported a position in Elevance Health in Q1 2017 and has held it in 34 quarters since.
- Oppenheimer Asset Management's Elevance Health position peaked at $6.63M in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.